Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Amgen to acquire Avidia

October 5, 2006 Research and Development, Sales and Marketing

Amgen is to pay $290 million to buy Avidia, a Californian biotech company which is developing innovative new protein-based medicines.Based …
News

Novartis’ MS drug shows further promise

October 2, 2006 Research and Development

A new treatment for multiple sclerosis currently being developed by Novartis has shown further promise in slowing the progress of …
News

Two new AstraZeneca laboratories opened in UK

September 29, 2006 Research and Development

AstraZeneca has officially opened two major research laboratories in the UK, which it says demonstrates its commitment to R&D in …
News

AZ and Schering take novel approach in cancer collaboration

September 22, 2006 Research and Development

AstraZeneca and Schering are to co-develop a promising new drug candidate to treat breast cancer, with the two partners taking …
News

NicOx to develop enhanced statin product

September 6, 2006 Research and Development

NicOx is to develop a new statin treatment using its special in-house technology which, according to the company, could make …
News

Collaboration to develop new Parkinson’s Disease dyskinesia treatment

September 6, 2006 Research and Development

Santhera Pharmaceuticals is collaborating with Finnish biotech company Juvantia Pharma to develop a treatment for dyskinesia, the distressing involuntary movements …
News

AstraZeneca and charity spin-off collaborate on colorectal cancer research

September 4, 2006 Research and Development

AstraZeneca is to work with a spin-off company set up by Cancer Research UK to research and develop new treatments …
News

Women’s European pharma network launched

September 1, 2006 Research and Development, Sales and Marketing Europe, association, pharma

 Over the years, the numbers of women taking up positions of authority in the pharmaceutical industry has grown considerably, and …
Feature

The right stuff: execs with the Midas touch

August 31, 2006 Business Services, Research and Development biotech, management, recruitment

Here's a challenge: find someone with PhD-level scientific knowledge, a strong management track record and entrepreneurial flair. If there are …
Feature

GSK signs $1.5 billion drug discovery deal

August 31, 2006 Research and Development

GlaxoSmithKline has formed an alliance with Californian biotech company ChemoCentryx through its innovative drug development partnering unit.A licensing deal has …
News

MabThera shows promise in multiple sclerosis

August 29, 2006 Research and Development

The blockbuster non-Hodgkin's lymphoma treatment MabThera could offer a new treatment option for people with multiple sclerosis according to new …
News

Time to get back to our scientific basics

August 23, 2006 Research and Development biotech, drug safety, industry reputation

Recently I was wandering through the local market, and found myself in front of a stall selling therapeutic magnets. I …
Feature

New broom Kindler sweeps away Pfizer bureaucracy

August 21, 2006 Research and Development, Sales and Marketing

Pfizer's new chief executive Jeffery Kindler has unveiled changes to the company's senior management structure just days into his new …
News

Head-to-head: Nice and the SMC

August 16, 2006 Research and Development, Sales and Marketing NICE, SMC, healthcare

The announcements on NHS budget deficits and the debates surrounding the prescribing of costly drugs, such as in the  Herceptin …
Feature

Vernalis takes diabetes pain drug into phase II

August 15, 2006 Research and Development Vernalis

UK biotech company Vernalis has started enrolment into a phase II trial of V3381, a drug designed for patients with …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026